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ABSTRACT: Our aim was to contribute to a better understanding of the pathophysiology of anemia in 
elderly, by studying how aging affects renal function, iron metabolism, erythropoiesis and the inflammatory 
response, using an experimental animal model. The study was performed in male Wistar, a group of young 
rats with 2 months age and an old one with 18 months age. Old rats presented a significant higher urea, 
creatinine, interferon (INF)-gamma, ferritin and soluble transferrin receptor serum levels, as well as 
increased counts of reticulocytes and RDW. In addition, these rats showed significant lower erythropoietin 
(EPO) and iron serum levels. Concerning gene expression of iron regulatory proteins, old rats presented 
significantly higher mRNA levels of hepcidin (Hamp), transferrin (TF), transferrin receptor 2 (TfR2) and 
hemojuvelin (HJV); divalent metal transporter 1 (DMT1) mRNA levels were significantly higher in duodenal 
tissue; EPO gene expression was significantly higher in liver and lower in kidney, and the expression of the 
EPOR was significantly higher in both liver and kidney. Our results showed that aging is associated with 
impaired renal function, which could be in turn related with the inflammatory process and with a decline in 
EPO renal production. Moreover, we also propose that aging may be associated with INF-gamma-induced 
inflammation and with alterations upon iron regulatory proteins gene expression. 
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Epidemiological studies show an increased occurrence of 
anemia with aging, with a prevalence of about 5% at 65 
years, to more than 20% at the age of 85 years [1,2]. 
Previous studies showed that anemia, per se, is associated 
with higher morbidity, risk of hospitalization, and 
mortality rates [2,3]. When the identifiable causes of 
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anemia are excluded, such as erythropoietic nutrient 
deficiencies, inflammatory conditions and chronic kidney 
disease (CKD), the prevalence of anemia is still high in 
the elderly population. In fact, several studies showed that 
as much as 1/3 of the anemia in older population is of 
unexplained cause [4-6].  Some possible explanations for 
the increased prevalence of anemia of unknown etiology 
in advancing age have been suggested [7-10]. Indeed, 
aging is characterized by a progressive mild pro-
inflammatory status, as shown by the rising levels of pro-
inflammatory markers [11]. This phenomenon can be 
partially explained by the increasing prevalence of 
chronic diseases; however, even when healthy older 
individuals were studied, they still had higher levels of 
pro-inflammatory cytokines and acute phase reactive 
proteins [11-14]. Additionally, a positive association 
between inflammation and erythropoietin (EPO) serum 
levels has been reported in old individuals without anemia 
[13]. These findings suggest that inflammation might 
hamper the response to EPO. Furthermore, it is known 
that increased levels of hepcidin (Hamp) are involved in 
the pathogenesis of the anemia of inflammation [10,11]. 
Nevertheless, it is still unclear whether the mild-pro-
inflammatory state associated with aging, causes Hamp 
up-regulation and contributes to the development of 
anemia. More recently, it was reported that the anemia of 
chronic diseases is dependent on interferon-γ and that this 
cytokine reduces both the life span and the production of 
red blood cells [14]. This effect upon red blood cells has 
been attributed to interferon-γ capacity of inducing the 
expression of transcription factors of interferon regulatory 
factor-1 and PU.1 in human erythroid precursors, leading 
to inhibition of erythropoiesis.  
Aging is also associated with physiological, 
functional and morphological changes in kidneys, which 
are similar to those found in CKD, though to a lesser 
extent [15]. Inflammation is also associated to aging-
related diseases, and to progression of CKD [16]. The 
kidney is the major local of EPO synthesis, and one of the 
mechanisms proposed for the pathogenesis of the 
unexplained anemia in older people is an inadequate EPO 
production. In fact, it has been suggested that the ability 
of kidneys to secrete EPO in response to tissue hypoxia 
declines with aging. However, EPO levels in non-anemic 
older persons are conflicting, as some studies showed 
higher EPO levels, and other studies do not confirm that 
finding [17].  
The aim of this work was therefore to contribute to a 
better understanding of the pathophysiology of anemia in 
elderly, by studying how aging affects renal function, iron 
metabolism and the inflammatory response, using for that 
purpose an experimental animal model; old male Wistar 
rats, aged 18 moths, were compared to young  male Wistar 
rats, aged 2 months. The determinations included 
analytical blood studies (basic hematological study, 
reticulocyte count, glucose, urea and creatinine levels, C-
reactive protein, interleukin-6, interferon-γ, iron, ferritin, 
transferrin, soluble transferrin receptor and erythropoietin 
concentrations) kidney histopathological studies and gene 
expression analysis of transferrin receptor 2 (TfR2), 
hepcidin (Hamp), ferroportin (SLC40A1), hemojuvelin 
(HJV), transferrin (TF), hemochromatosis (Hfe) in liver 
tissue; divalent metal transporter 1 (DMT1) gene 
expression in duodenal tissue, as well EPO and EPO 
receptor (EPOR) gene expression in both liver and kidney. 
 
MATERIAL AND METHODS 
 
Animals and groups 
 
Two groups of male Wistar rats (Charles River Lab. Inc., 
Barcelona, Spain) were evaluated in this study: one of 
young rats, with only 2 months of age (n=8) and the other 
of natural aging rats, with 18 months of age (n=7). The 
rats were maintained in an air-conditioned room, 
subjected to 12 h dark/light cycles and given standard 
laboratory rat diet (IPM-R20, Letica, Barcelona, Spain) 
and free access to tap water. Animal experiments were 
conducted according to the European Communities 
Council Directives on Animal Care and to the National 
Authorities, and the study received approval from the 
Institutional Ethics Committee of the Faculty of Medicine 
from the University of Coimbra. Approval ID: 
FMUC/10/11. 
During the entire experimental protocol, the body 
weight and the amount of beverage consumption were 
monitored.  
 
Blood and tissue collection 
 
At the end of the experimental protocol the rats were 
submitted to intraperitoneal anesthesia with 2.0 mg/kg of 
a 2:1 (v:v) 50.0 mg/mL ketamine (Ketalar®, Parke-Davis, 
Pfizer Laboratories Lda, Seixal, Portugal) solution in 
2.5% chlorpromazine (Largatil®, Rhône-Poulenc Rorer, 
Vitória Laboratories, Amadora, Portugal). Blood samples 
were immediately collected by venepuncture from the 
jugular vein into vacutainer tubes with anticoagulant 
(EDTA) and without anticoagulant, in order to obtain 
whole blood, plasma and serum. Under anesthesia the rats 
were sacrificed by cervical dislocation, and the liver, 
heart, kidneys and duodenum were immediately removed, 
weighed and placed in ice-cold Krebs buffer; the organs 
were carefully cleaned from adherent fat and connective 
tissue. Two small portions of the liver, kidney and 
duodenum from each rat were prepared for 
histopathological analysis (further placed in 
formaldehyde) and for the genetic studies; to isolate total 
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RNA, 0.2 g samples of liver, duodenum and kidney, from 
each rat, were immersed in RNA laterTM (Ambion, Austin, 
USA) and stored at 4 °C for 24h; afterwards, samples were 
frozen at -80oC. The body weight (BW) and the weight of 
kidneys (KW), heart weight (HW) and left ventricle 
weight (LVW) were used to calculate the tropism indexes 
(KW/BW, HW/BW, LVW/HW and LVW/BW). 
 
 
 
Table 1. Body and tissue weight, trophism indexes, hematological, biochemical and 
inflammatory data, iron metabolism and EPO levels in young and old rats 
 
 
*p<0.05 vs. young rats; **p=0.056 vs. young rats; ***p=0.065 vs. young rats; results are presented as mean ± s.e.m.  
BW: body weight; HW: heart weight; LVW: left ventricle weight; KW: Kidney weight; RBC: red blood cell; MCV: 
mean cell volume; MCH: mean cell hemoglobin; MCHC: mean cell hemoglobin concentration; RDW: red blood cell 
distribution width; hsCRP: high sensitive C-reactive protein; IL-6: interleukin-6; INF-: interferon-gamma; sTfR: 
soluble transferrin receptor; EPO: erythropoietin.  
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Hematological data 
 
Erythrocyte, leukocyte and platelet counts, hematocrit, 
hemoglobin concentration and hematimetric indices 
[mean cell volume (MCV), mean cell hemoglobin (MCH) 
and mean cell hemoglobin concentration (MCHC)] were 
measured by using an automatic blood cell counter 
(Sysmex K1000; Sysmex, Hamburg, Germany). 
Reticulocyte count was performed by microscopic 
counting on blood smears after vital staining with new 
methylene blue (reticulocyte stain; Sigma, St. Louis, Mo., 
USA).  
 
Biochemical data 
 
Serum levels of creatinine, urea and glucose 
concentrations were analyzed on a Hitachi 717 analyzer 
(Roche Diagnostics Inc., Massachuasetts, USA) using 
standard methods.  
Serum iron concentration was determined using a 
colorimetric method (Iron, Randox Laboratories Ltd., 
North Ireland, UK), whereas serum ferritin and serum 
transferrin were measured by immunoturbidimetry 
(Ferritin, Laboratories Ltd., North Ireland, UK; 
Transferrin, Laboratories Ltd., North Ireland, UK). An 
enzyme-linked immunosorbent assay was used to 
measure plasma soluble transferrin receptors (s-TfR) 
(Human sTfR immunoassay, R&D systems, MN, USA). 
Serum levels of interleukin-6 (IL-6) and interferon-  
(IFN-), were measured by rat-specific Quantikine ELISA 
kits from R&D Systems (Minneapolis, USA). High-
sensitive C-reactive protein (hsCRP) was determined by 
using a rat-specific Elisa kit from Alpha Diagnostic 
International (San Antonio, USA). Serum erythropoietin 
(EPO) concentrations were measured by rat ELISA kit 
(Eiaab Science Co. Ltd, Wuban, China). All assays were 
performed according to the manufacturers’ 
recommendations, in duplicate. 
 
Kidney histopathological analysis 
 
Renal tissue samples were fixed in Bock's fixative and 
embedded in paraffin wax; afterwards, 4 μm thick sections 
were stained with hematoxylin and eosin (HE) for routine 
histopathological analysis.  
To quantify renal lesions we also performed a 
Periodic Acid of Schiff (PAS) staining. Renal tissue 
samples were fixed in 10% neutral formalin and 
embedded in paraffin wax; tissue sections, 4 μm thick, 
were prepared and mounted on slides that were immersed 
in water and subsequently treated with an aqueous 
solution of periodic acid (1%); slides were washed to 
remove any traces of the periodic acid, and, finally, were 
treated with Schiff's reagent. All samples were examined 
by light microscopy using a Microscope Zeiss Mod. 
Axioplan 2. The degree of injury was scored in a double-
blinded fashion by two independent pathologists. Lesions 
were evaluated on the total tissue on the slide. 
Glomerular damage was assessed by evaluating 
mesangial expansion, glomerular basement membrane 
and capsule of Bowman thickening, nodular sclerosis, 
glomerulosclerosis, atrophy, and hyalinosis of the 
vascular pole. Tubulointerstitial lesions were assessed by 
inflammatory infiltration, presence of hyaline cylinders, 
tubular basement membrane irregularity, tubular 
calcification, and by the association of interstitial fibrosis 
and tubular atrophy (IFTA). The evaluation of vascular 
lesions was concentrated on arteriolar hyalinosis, 
arteriolosclerosis and arteriosclerosis. A semi-
quantitative rating for each slide, ranging from normal (or 
minimal) to severe (extensive damage), was assigned to 
each component. Severity was graded as absent/normal 
(0), mild (1), moderate (2), and severe (3). Scoring was 
defined according to the extension occupied by the lesion 
(number of capsules): normal: 0%; mild: <25%; 
moderate: 25–50%; severe: >50%. The final score for 
each sample was obtained by the average scores observed 
in individual glomeruli in the considered microscopic 
fields. Tubular calcification was evaluated and graded by 
the same semiquantitative method. Regarding vascular 
lesions, arteriosclerosis was scored as 0 if no intimal 
thickening was present, as 1 if intimal thickening was less 
than the thickness of the media, and as 2 if intimal 
thickening was more than the thickness of the media and 
considering the worst artery on the slide. Using PAS, the 
rating was set for intensity and extension of staining, 
ranging from 0 (no staining) to 3 (intense and extensive 
staining), respecting tissue specificity scoring when 
adequate. 
 
Gene expression analysis 
 
Tissue samples (50±10 mg) immersed in RNA laterTM 
were homogenized in 1 ml TRI® Reagent (Sigma, Sintra, 
Portugal), using a homogenizer, and total RNA was 
isolated as described in the TRI® Reagent Kit. To ensure 
inactivation of contaminating RNAses, metal objects and 
glassware were cleaned with detergent, immersed in 
RNAse-free water (0.2% diethyl pyrocarbonate) for 2 h 
and, finally, heated at 120oC for 1 h. RNA integrity (RIN, 
RNA Integrity Number) was analyzed using 6000 Nano 
ChipW kit, in Agilent 2100 bioanalyzer (Agilent 
Technologies, Walbronn, Germany) and 2100 expert 
software, following manufacturer instructions. The yield 
from isolation ranged from 0.5 to 1.5 μg; RIN values were 
7.0–9.0 and purity (A260/A280) was 1.8–2.0. The 
concentration of the RNA preparations were confirmed 
with NanoDrop1000 (ThermoScientific, Wilmington, 
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DE, USA). Possible contaminating remnants of genomic 
DNA were eliminated by treating these preparations with 
deoxyribonuclease I (amplication grade) prior to RT-
qPCR amplification. Reverse transcription and relative 
quantification of gene expression were performed as 
previously described [18]. Real-time qPCR reactions 
were performed using the following primer sequences for 
EPO, EPOR, Transferrin receptor 2 (TfR2), Hepcidin 
(Hamp), Ferroportin (SLC40A1), Hemojuvelin (HJV), 
Transferrin (TF), Hemochromatosis (Hfe) and Divalent 
Metal Transporter 1 (DMT1), which were normalized in 
relation to the expression of beta-actin (Actb), and 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH): 
EPO Forward: AGG GTC ACG AAG CCA TGA AG, 
EPO Reverse: GAT TTC GGC TGT TGC CAG TG; 
EPOR Forward: GCG ACT TGG ACC CTC TCA TC, 
EPOR Reverse: AGT TAC CCT TGT GGG TGG TG; 
TfR2 Forward: CAA GCT TCG CCC AGA AGG TA, 
TfR2 Reverse: CGT GTA AGG GTC CCC AGT TC; 
Hamp Forward: GAA GGC AAG ATG GCA CTA AGC, 
Hamp Reverse: CAG AGC CGT AGT CTG TCT CG; 
SLC40A1 Forward: CAG GCT TAG GGT CTA CTG CG 
, SLC40A1 Reverse: CCG AAA GAC CCC AAA GGA 
CA; HJV Forward: GCC TAC TTC CAA TCC TGC GT, 
HJV Reverse: GGT CAA GAA GAC TCG GGC AT; TF 
Forward: GGC ATC AGA CTC CAG CAT CA, TF 
Reverse: GCA GGC CCA TAG GGA TGT T; Hfe 
Forward: CTG GAT CAG CCT CTC ACT GC, Hfe 
Reverse: GTC ACC CAT GGT TCC TCC TG; DMT1 
Forward: CAA CTC TAC CCT GGC TGT GG, DMT1 
Reverse: GTC ATG GTG GAG CTC TGT CC; GAPDH 
Forward: CCA CTA AAG GGC ATC CTG GG, GAPDH 
Reverse: CAT TGA GAG CAA TGC CAG CC; Actb 
Forward: GAG ATT ACT GCC CTG GCT CC, Actb 
Reverse: CGG ACT CAT CGT ACT CCT GC. Results 
were analyzed with SDS 2.1 software (Applied 
Biosystems, Foster City, CA, USA) and the relative 
quantification was calculated by using the 2ΔΔCt method 
[19]. 
 
Table 2.  Scoring and distribution of glomerular and tubular lesions in the groups under study at the final time 
 
 
 
Data analysis 
 
For statistical analysis, we used the Statistical Package for 
Social Sciences (SPSS), version 19.0. Results are 
presented as mean ± s.e.m. Comparisons between groups 
were performed using Mann-Whitney U test. Significance 
was accepted at p less than 0.05. 
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Figure 1.  Transferrin receptor 2 (TfR2), hepcidin (Hamp), ferroportin (SLC40A1), hemojuvelin (HJV), 
transferrin (TF), hemochromatosis (Hfe) gene expression in liver tissue for both groups of rats (young and old). 
 
 
 
 
RESULTS 
 
The results were analyzed by comparing the two groups 
under study – young and old rat groups. The old rats 
presented a significant higher BW, in HW and KW, when 
compared with young rats. However, a significant 
decrease in all tissue trophy indexes was found for old rats 
group (table I).  
The hematological study showed a trend towards a 
lower erythrocyte count, hematocrit and hemoglobin 
concentration in old rats, which was associated with a 
significant higher RDW and lower reticulocyte count, that 
almost achieved statistical significance (p= 0.065). A 
significant higher urea and creatinine serum levels was 
also found in old rats. Moreover, higher levels of INF-, 
ferritin and transferrin, as well as a significant decrease in 
EPO and lower iron serum levels were seen for old rats 
(table I).  
Iron regulatory proteins gene expression, in liver 
tissue of old rats, showed a significant higher Hamp, TF, 
TfR2, and HJV expression; a trend towards a higher gene 
expression was also observed for SLC40A1 and HFE (Fig. 
1). We also found in old rats duodenum, a higher DMT1 
expression (Fig. 2). Additionally, EPO gene expression 
was also significantly up-regulated in liver, while down-
regulated in kidney; expression of EPOR was 
significantly up-regulated in both liver and kidney tissues 
(Fig. 3). 
Concerning to kidney histomorphology (table II), we 
found that only old rats presented glomerular lesions 
(mild-to-moderate), namely thickening of CB (mild 
57.1%; moderate 14.3%), hyalinosis of vascular pole (in 
the entire group), dilatation of the Bowman s´ Space (mild: 
28.6%) (Fig.4A), and hypercellularity (mild 57.1%; 
moderate 14.3%); the entire group also presented mild to 
moderate tubular lesions (table II), such as IFTA, 
interstitial inflammatory infiltration, hyaline cylinders 
and vacuolar tubular degeneration. Regarding vascular 
lesions, old rats showed arteriosclerosis and 
arteriolosclerosis (Fig. 4B).  
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Figure 2. Divalent metal transporter 1 (DMT1) gene 
expression in duodenal tissues.  
 
 
DISCUSSION 
 
Most of the studies performed to clarify the 
pathophysiology of anemia of the elderly, were performed 
in old humans. The frequent association of comorbidities 
and polypharmacy to advanced age, turns very difficult 
the study of the etiology and pathophysiology of this 
particular anemia. However, it would be important to 
understand how biological changes occurring with aging, 
underlie the development of an unexplained anemia, as 
occurs in one third of elderly patients with anemia. To 
achieve this, it would be necessary to analyze the crosstalk 
between anemia, inflammation and iron metabolism, by 
performing diverse studies at blood, tissue and molecular 
levels, in old individuals. Since these types of studies are 
not ethical in healthy old humans, we performed them 
using a natural aged rat model. 
 
 
 
 
Figure 3. Erythropoietin (EPO) and erythropoietin receptor (EPOR) gene 
expression in liver (A and C) and kidney (B and D).  
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Figure 4. Renal histological changes associated with aging.  (A) Example of atherosclerotic grade 
1 lesions found in arteries of old rats (X40), intimal thickening (I) less than thickness of media (M).  
(B) Dilatation of the Bowman s´ Space (X20), N–normal glomerulus, BS – Bowman s´ Space. (C) 
Arteries of young rats without changes (X40). (D) Normal glomerulus.   
 
 
In this study, our model does not present yet anemia, 
since these rats are not very old. However, they presented 
already higher inflammatory markers and alterations in 
renal function and in iron metabolism, associated with 
mild erythropoietic disturbances. These data could be 
helpful to better understand the modifications that could 
lead to the development of anemia associated with aging. 
However, it seems important, in the future, to evaluate an 
older model (i.e. 24 months) that might highlight the 
erythropoietic, renal and inflammatory changes already 
observed in this model with “just” 18 months of age.  
We found that our aged rat model has an impaired 
renal function, as shown by the significantly increased 
levels of urea and creatinine, associated with a significant 
decrease in its ability to secrete EPO; the kidney 
weight/body trophy index was significantly decreased and 
several histological changes in renal tissue were also 
observed. Indeed, concerning to glomerular lesions, the 
entire group showed mild hyalinosis of the vascular pole 
and the majority showed mild to moderate thickening of 
CB, dilation of the Bowman’s space and hypercellularity; 
in addition, all the old rats showed tubular lesions, 
presenting hyaline cylinders, TBM irregularity, IFTA, 
interstitial inflammatory inflammation and vacuolar 
tubular degeneration. None of the young rats presented 
such histological findings. 
  Age-related changes in renal structure and function 
are well documented in humans and in a wide range of 
animal species [15]. Actually, renal function has been 
proposed as one of the major predictors of longevity [20]. 
However, the etiology of renal function decline and 
structural changes with aging are poorly clarified and 
have been related with several factors, namely, with 
comorbidities associated to oxidative stress and 
inflammation. 
The ability of the kidney to secrete EPO in response 
to hypoxia seems to decline with aging, despite the 
controversial data [21-23]. In fact, one of the proposed 
mechanisms for the pathogenesis of the unexplained 
anemia in elderly is an inadequate EPO production.  
As already referred, we found that old rats present 
lower EPO levels and lower numbers of reticulocytes, 
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associated to a slightly lower hemoglobin concentration, 
which suggests a decreased eryhtropoietic stimuli and, 
therefore, a reduced reticulocyte production; in 
accordance, we found that EPO gene was down-regulated 
in the kidneys; oppositely, we found an increased EPO 
expression in hepatic tissue, which may be the result of a 
compensatory mechanism to overcome the decrease in 
renal EPO production.   
Besides the hematopoietic effect of EPO, it is known 
that EPO has a pleiotropic action, which might include 
renal, cardiovascular and nervous systems 
protection/regeneration [18, 24]. It has been reported that 
EPO has different intracellular signaling pathways in the 
kidney tissue, such as the PI3K/Akt pathway, a signaling 
pathway crucial for cell survival. In the present work, we 
found that old rats have an increased EPOR expression in 
both liver and kidney tissues, which might be a response 
to diminished EPO serum levels, in order to maximize the 
protective/regenerative effect of circulating EPO.  
Several authors have previously proposed that the 
anemia of unexplained etiology in elderly could have an 
inflammatory component [4-6]. An underlying 
inflammatory process leads to increased Hamp levels, the 
pivotal iron-regulatory peptide. Hamp acts as a negative 
regulator of intestinal iron absorption and inhibits the 
release of iron to be used in hemoglobin synthesis, from 
macrophages and hepatocytes, through the degradation of 
ferroportin, localized at the membrane surface of 
enterocytes, hepatocytes and macrophages; Hamp seems 
to represent the molecular link between chronic 
inflammation, body iron status and anemia.  A high Hamp 
production occurs in inflammatory and infectious 
diseases, leading to the development of anemia, known as 
the anemia of inflammation.  
In our model, the aged rats presented a decrease in 
iron serum levels, accompanied by an increase in ferritin 
and transferrin serum levels. These results suggest that 
aging is associated with a disturbance in iron metabolism, 
decreasing its iron availability for erythropoiesis, in spite 
of the increased iron storage. It is well documented that 
the gene encoding Hamp synthesis, in the liver, is 
regulated mainly by inflammatory cytokines, namely by 
IL-6 [25,26]. The old rats, as compared to young ones, 
presented an increased expression of Hamp gene; 
however, it is still unclear whether chronic inflammation 
and especially the mild-pro-inflammatory state associated 
with aging, causes Hamp up-regulation and contributes to 
anemia of aging. Indeed, IL-6 serum levels were not 
significantly different between young and old rats, 
suggesting that the mechanism underlying the up-
regulation of Hamp gene expression is not related with IL-
6 activating pathway. In accordance, we found that old 
rats presented increased hepatic TF, TfR2 and HJV gene 
expressions, which, are known to up-regulate Hamp 
expression [26,27]. Moreover, old rats presented 
increased ferritin serum levels, which are known to up-
regulate Hamp gene expression in the liver [27]. In 
addition, as referred previously, kidney EPO gene 
expression and EPO circulating levels were decreased, 
which are known to up-regulate the Hamp expression.  
INF- has been shown to have a direct suppressive 
effect on the formation of erythroid colonies in vitro [14]. 
However, the molecular mechanism by which INF- 
inhibits erythroid differentiation is still poorly clarified. 
Old rats presented a significant reduction in circulating 
reticulocytes, suggesting a reduction in erythropoiesis. 
Furthermore, sTfR are usually increased when iron is not 
available for erythroid cells, and decreased when 
erythropoiesis is reduced. The reduced mean value 
observed for sTfR in old rats seems to result, mainly, from 
a reduction in erythropoiesis process. 
We also found in our aged rats an increase in DMT1 
gene expression at duodenal level, probably, reflecting an 
attempt to increase duodenal iron absorption, to 
counteract the low iron serum levels.  
Our results show that aging is associated with 
impaired renal function, which might be related to the 
inflammatory process and sclerosing modifications found 
in the renal tissue. These structural and functional kidney 
changes could lead to a decline in EPO renal production, 
reducing the erythropoietic stimuli. Moreover, we also 
showed that aging is associated with INF-induced 
inflammation and with changes in iron regulatory protein 
gene expression, including an increase in Hamp 
expression that will further alter erythropoiesis, by 
reducing iron absorption and mobilization. The increased 
hepatic EPO expression could be the result of a 
compensatory mechanism to overcome the decrease in 
renal EPO production. The increased EPOR expression, 
in both liver and kidney, might represent a 
protection/regenerating mechanism to counteract tissue 
aging.  
In conclusion, the anemia of the elderly seems to 
result from the interplay between renal, inflammatory and 
erythropoietic disturbances. A better understanding of the 
pathophysiological mechanisms underlying this yet 
unexplained anemia will improve the possibility to 
develop therapeutics strategies directed to this condition, 
in order to reduce the high healthy and socioeconomic 
cost associated with the disease. 
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